adimin

Evolv Technology under SEC investigation

WALTHAM, Mass. - Evolv Technology (NASDAQ: EVLV), a company specializing in AI-based weapons detection systems, disclosed today that it is the subject of a Securities and Exchange Commission (SEC) investigation. The SEC\'s inquiry, which began on Friday, February 16, 2024, is described as a confidential and non-public fact-finding mission. The SEC has clarified that this...

Read More

CalciMedica stock target raised to $9.50 by Singular Research amid new fund

On Monday, Singular Research adjusted its outlook on CalciMedica (NASDAQ:CALC), a biopharmaceutical company, raising the price target to $9.50 from the previous $6.25. The firm sustained its Buy-Venture rating on the stock. This adjustment comes in the wake of new funding that is expected to bolster CalciMedica\'s progress with its highest pipeline priorities. The analyst...

Read More